These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11642473)

  • 1. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A crossover study of risperidone in children, adolescents and adults with mental retardation.
    Hellings JA; Zarcone JR; Reese RM; Valdovinos MG; Marquis JG; Fleming KK; Schroeder SR
    J Autism Dev Disord; 2006 Apr; 36(3):401-11. PubMed ID: 16596465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.
    Hellings JA; Zarcone JR; Valdovinos MG; Reese RM; Gaughan E; Schroeder SR
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):885-92. PubMed ID: 16379508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
    Cohen S; Glazewski R; Khan S; Khan A
    J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.
    Zarcone JR; Hellings JA; Crandall K; Reese RM; Marquis J; Fleming K; Shores R; Williams D; Schroeder SR
    Am J Ment Retard; 2001 Nov; 106(6):525-38. PubMed ID: 11708938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
    Lindsay RL; Eugene Arnold L; Aman MG; Vitiello B; Posey DJ; McDougle CJ; Scahill L; Pachler M; McCracken JT; Tierney E; Bozzolo D
    J Intellect Dev Disabil; 2006 Dec; 31(4):204-9. PubMed ID: 17178532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone and explosive aggressive autism.
    Horrigan JP; Barnhill LJ
    J Autism Dev Disord; 1997 Jun; 27(3):313-23. PubMed ID: 9229261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
    Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
    Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self injurious behavior in autism: clinical aspects and treatment with risperidone.
    Canitano R
    J Neural Transm (Vienna); 2006 Mar; 113(3):425-31. PubMed ID: 16075185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
    Buitelaar JK
    J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardation.
    Kumazaki H; Watanabe K; Imasaka Y; Iwata K; Tomoda A; Mimura M
    J Clin Psychopharmacol; 2014 Oct; 34(5):624-6. PubMed ID: 25118082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.
    Gencer O; Emiroglu FN; Miral S; Baykara B; Baykara A; Dirik E
    Eur Child Adolesc Psychiatry; 2008 Jun; 17(4):217-25. PubMed ID: 18026891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.